跳至主要内容
临床试验/KCT0006805
KCT0006805已完成未知

Adequate infusion rate of remimazolam for induction of general anesthesia in adult patients

Samsung Medical Center0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 64(Year)(—)
性别
All

入选标准

  • 1) ASA class I - III
  • 2) Age between 19 to 65
  • 2) Patient who has elective surgery under general anesthesia

排除标准

  • 1) Children (under 18 years old)
  • 2) BMI>30kg/m2 or <18.5kg/m2
  • 3) People with severe liver disease
  • 4) Neuromuscular disease or mental illness
  • 5) metabolic disease
  • 6) drug or alcohol addiction
  • 7) Emergency surgery
  • 8) Pregnant women, lactating women
  • 9) Those who are contraindicated in benzodiazepine drugs and sevoflurane (e.g., patients who are allergic to drugs or have a history of hypersensitivity reactions)
  • 10) Patients with acute narrow-angle glaucoma
  • 11) Patients in shock or coma
  • 12) Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption
  • 13) Patients with severe hypersensitivity to dextran 40
  • 14) If patient's anesthesiologist refuses to use remimazolam
  • 15) Patients with sleep apnea syndrome
  • 16) Patients with severe or acute respiratory failure

研究者

相似试验